Rick Crowley

Mr. Crowley is chief operations officer with responsibility for all operations, including Quality, Manufacturing, Supply Chain and Regulatory Affairs. He joined Novavax in December 2020, bringing more than two decades of experience in biopharmaceutical operations and executive management. Prior to joining Novavax, Mr. Crowley was executive vice president, technical operations at TerSera Therapeutics, where he held responsibility for technical support, development and strategy for the company’s products, created the initial quality systems and managed all technical CMC activities., Mr. Crowley served as senior vice president, operations and quality assurance for Crealta Pharmaceuticals 2014-2016, where he was responsible for supply chain, quality systems and the global regulatory affairs. Earlier, Mr. Crowley held the role of co-president and chief operating officer at Savient Pharmaceuticals. Mr. Crowley holds a bachelor of science degree in chemistry from Denison University and a master of science degree in chemical engineering from the University of Pennsylvania.